This software is designed for use in conjunction with the Kit and the high-throughput sequencer . By utilizing cell-free DNA sequences from the peripheral blood plasma of high-risk, singleton pregnant women during 12-24 gestational weeks, the software calculates the number of chromosomes 13, 18, and 21 in the fetus, thereby assessing the risk of trisomy 13, 18, or 21.